Rockies prospect David Dahl requires surgery on spleen after outfield collision


According to Yahoo Sports’ Jeff Passan, Rockies prospect outfielder David Dahl required surgery on his spleen today following an outfield collision in a game with Double-A New Britain. The 21-year-old will miss the rest of the season.

Dahl collided with second baseman Juan Ciriaco when they converged on a fly ball in shallow center field. You can watch the play here.

Dahl’s father, Mike Dahl, was in attendance for the game and rode with his son in the ambulance. He told the Mobile Press-Register earlier in the day that doctors were “trying to save the spleen.” Surgery on the “massive laceration” was successful, but Passan notes that Dahl will likely have to wear some sort of protective gear for the rest of his career.

Dahl was selected 10th overall by the Rockies in 2012. After being limited to just 10 games in 2013 due to a suspension for disciplinary reasons and a torn hamstring, he enjoyed a breakout season last year and was ranked as the No. 22 prospect in the game by Baseball America this spring. Dahl was batting .269/.296/.379 line with three home runs, 16 RBI, and 14 stolen bases through his first 44 games in Double-A this season. Here’s hoping things get back to normal for him soon.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.